Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to demonstrate the long-term safety and tolerability
of MCI-196 in the subjects with stage V chronic kidney disease on dialysis with
hyperphosphatemia.
The secondary objective of this study is to assess the long-term efficacy of flexible doses
of MCI-196.